Anterogen.Co.,Ltd. (065660.KQ)

KRW 16060.0

(-6.3%)

Long Term Debt Summary of Anterogen.Co.,Ltd.

Anterogen.Co.,Ltd.'s latest annual long term debt in 2023 was - KRW , down 0.0% from previous year.
Anterogen.Co.,Ltd.'s latest quarterly long term debt in 2024 Q2 was - KRW , down 0.0% from previous quarter.
Anterogen.Co.,Ltd. reported annual long term debt of - KRW in 2022, down 0.0% from previous year.
Anterogen.Co.,Ltd. reported annual long term debt of - KRW in 2021, down 0.0% from previous year.
Anterogen.Co.,Ltd. reported quarterly long term debt of - KRW for 2024 Q2, down 0.0% from previous quarter.
Anterogen.Co.,Ltd. reported quarterly long term debt of - KRW for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Anterogen.Co.,Ltd. (2023 - 2015)

Historical Annual Long Term Debt of Anterogen.Co.,Ltd. (2023 - 2015)

Year	Long Term Debt	Long Term Debt Growth
2023	- KRW	0.0%
2022	- KRW	0.0%
2021	- KRW	0.0%
2020	- KRW	0.0%
2019	- KRW	-100.0%
2018	10.32 Billion KRW	146.26%
2017	4.19 Billion KRW	0.0%
2016	- KRW	0.0%
2015	- KRW	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	- KRW	0.0%
2024 Q2	- KRW	0.0%
2023 Q2	- KRW	0.0%
2023 Q4	- KRW	0.0%
2023 FY	- KRW	0.0%
2023 Q1	- KRW	0.0%
2023 Q3	- KRW	0.0%
2022 FY	- KRW	0.0%
2022 Q4	- KRW	0.0%
2022 Q3	- KRW	0.0%
2022 Q1	- KRW	0.0%
2022 Q2	- KRW	0.0%
2021 Q4	- KRW	0.0%
2021 FY	- KRW	0.0%
2021 Q3	- KRW	0.0%
2021 Q1	- KRW	0.0%
2021 Q2	- KRW	0.0%
2020 Q2	- KRW	0.0%
2020 Q3	- KRW	0.0%
2020 Q4	- KRW	0.0%
2020 FY	- KRW	0.0%
2020 Q1	- KRW	0.0%
2019 Q3	- KRW	0.0%
2019 Q2	- KRW	0.0%
2019 Q1	- KRW	0.0%
2019 FY	- KRW	-100.0%
2019 Q4	- KRW	0.0%
2018 Q3	11.41 Billion KRW	1.53%
2018 Q4	- KRW	-100.0%
2018 FY	10.32 Billion KRW	146.26%
2018 Q1	4.22 Billion KRW	0.64%
2018 Q2	11.24 Billion KRW	166.31%
2017 Q3	10 Billion KRW	0.0%
2017 Q1	- KRW	0.0%
2017 Q2	- KRW	0.0%
2017 Q4	4.19 Billion KRW	-58.05%
2017 FY	4.19 Billion KRW	0.0%
2016 FY	- KRW	0.0%
2016 Q1	- KRW	0.0%
2016 Q2	- KRW	0.0%
2016 Q4	- KRW	0.0%
2016 Q3	- KRW	0.0%
2015 Q4	- KRW	0.0%
2015 FY	- KRW	0.0%

Peer Long Term Debt Comparison of Anterogen.Co.,Ltd.

Name	Long Term Debt	Long Term Debt Difference
HLB Co., Ltd.	17.93 Billion KRW	100.0%
iNtRON Biotechnology, Inc.	258.29 Million KRW	100.0%
BINEX Co., Ltd.	5.57 Billion KRW	100.0%
Bioneer Corporation	12.5 Billion KRW	100.0%
MEDIPOST Co., Ltd.	6.99 Billion KRW	100.0%
CrystalGenomics, Inc.	29.88 Billion USD	100.0%
Helixmith Co., Ltd	151.68 Million KRW	100.0%
Chabiotech Co.,Ltd.	95.06 Billion KRW	100.0%
Medy-Tox Inc.	1.22 Billion KRW	100.0%
Peptron, Inc.	4.5 Billion KRW	100.0%
Amicogen, Inc.	70.65 Billion KRW	100.0%
Genexine, Inc.	22.68 Billion KRW	100.0%
HLB Therapeutics Co.,Ltd.	1.84 Billion KRW	100.0%
LegoChem Biosciences, Inc.	528.37 Million KRW	100.0%
ALTEOGEN Inc.	1.24 Billion KRW	100.0%
PharmaResearch Co., Ltd.	970.71 Million KRW	100.0%
SillaJen, Inc.	8.13 Billion KRW	100.0%
JETEMA, Co., Ltd.	60 Billion KRW	100.0%
OliX Pharmaceuticals,Inc	35.36 Billion KRW	100.0%
Genomictree Inc.	97.51 Million KRW	100.0%
MedPacto, Inc.	1.68 Billion KRW	100.0%
D&D Pharmatech	5.12 Billion KRW	100.0%
EASY BIO,Inc.	30 Billion KRW	100.0%
GI Innovation, Inc.	2.9 Billion KRW	100.0%